Silo Pharma (SILO) Revenue & Revenue Breakdown
Silo Pharma Revenue Highlights
Latest Revenue (Y)
$72.10K
Latest Revenue (Q)
$18.02K
Silo Pharma Revenue by Period
Silo Pharma Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $72.10K | - |
| 2022-12-31 | $72.10K | 1.18% |
| 2021-12-31 | $71.26K | 74.14% |
| 2020-12-31 | $40.92K | 0.87% |
| 2019-12-31 | $40.57K | 100.00% |
| 2018-12-31 | - | -100.00% |
| 2017-12-31 | $847.41K | -226.58% |
| 2016-12-31 | $-669.48K | 361.12% |
| 2015-12-31 | $-145.19K | 35.54% |
| 2014-12-31 | $-107.11K | -201.51% |
| 2013-12-31 | $105.52K | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2011-12-31 | - | - |
Silo Pharma generated $72.10K in revenue during NA 2023, up 0.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Silo Pharma Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $18.02K | - |
| 2024-06-30 | $18.02K | -0.01% |
| 2024-03-31 | $18.03K | - |
| 2023-12-31 | $18.03K | 0.01% |
| 2023-09-30 | $18.02K | - |
| 2023-06-30 | $18.02K | -0.01% |
| 2023-03-31 | $18.03K | - |
| 2022-12-31 | $18.03K | 0.01% |
| 2022-09-30 | $18.02K | - |
| 2022-06-30 | $18.02K | -0.01% |
| 2022-03-31 | $18.03K | - |
| 2021-12-31 | $18.03K | 0.01% |
| 2021-09-30 | $18.02K | -73.53% |
| 2021-06-30 | $68.08K | 43.54% |
| 2021-03-31 | $47.43K | 114.36% |
| 2020-12-31 | $22.13K | 35.88% |
| 2020-09-30 | $16.29K | 634.88% |
| 2020-06-30 | $2.22K | 653.74% |
| 2020-03-31 | $294.00 | -99.27% |
| 2019-12-31 | $40.30K | 14937.69% |
| 2019-09-30 | $268.00 | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | -100.00% |
| 2018-12-31 | $-44.00 | -344.44% |
| 2018-09-30 | $18.00 | -100.01% |
| 2018-06-30 | $-239.81K | -257.35% |
| 2018-03-31 | $152.40K | -59.49% |
| 2017-12-31 | $376.22K | -189.37% |
| 2017-09-30 | $-420.98K | -26510.54% |
| 2017-06-30 | $1.59K | -99.82% |
| 2017-03-31 | $890.58K | -1426.68% |
| 2016-12-31 | $-67.13K | -80.16% |
| 2016-09-30 | $-338.41K | 18.14% |
| 2016-06-30 | $-286.45K | -1372.72% |
| 2016-03-31 | $22.51K | -71.61% |
| 2015-12-31 | $79.27K | -119.09% |
| 2015-09-30 | $-415.30K | -546.11% |
| 2015-06-30 | $93.09K | -4.76% |
| 2015-03-31 | $97.75K | 10421.85% |
| 2014-12-31 | $929.00 | -100.50% |
| 2014-09-30 | $-184.25K | -53.11% |
| 2014-06-30 | $-392.94K | -183.76% |
| 2014-03-31 | $469.15K | 344.60% |
| 2013-12-31 | $105.52K | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | 100.00% |
| 2012-03-31 | - | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | - |
Silo Pharma generated $18.02K in revenue during Q3 2024, up 0.00% compared to the previous quarter, and up 100.00% compared to the same period a year ago.
Silo Pharma Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| URGN | UroGen Pharma | $82.71M | $25.20M |
| HOOK | HOOKIPA Pharma | $20.13M | - |
| IVA | Inventiva | $17.50M | $15.58M |
| IPSC | Century Therapeutics | $2.23M | $791.00K |
| LUMO | Lumos Pharma | $2.05M | $488.00K |
| STTK | Shattuck Labs | $1.66M | $1.61M |
| BCDA | BioCardia | $477.00K | $3.00K |
| SILO | Silo Pharma | $72.10K | $18.02K |
| ANEB | Anebulo Pharmaceuticals | - | - |
| RZLT | Rezolute | - | - |
| FBRX | Forte Biosciences | - | - |
| DAWN | Day One Biopharmaceuticals | - | $20.07M |
| ABOS | Acumen Pharmaceuticals | - | - |
| INZY | Inozyme Pharma | - | - |
| ELYM | Eliem Therapeutics | - | - |
| TPST | Tempest Therapeutics | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| PRDS | Pardes Biosciences | - | - |
| INDP | Indaptus Therapeutics | - | - |
| CSBR | Champions Oncology | - | - |